45
Cadrenal Therapeutics, Inc. raises $8.8M under Reg D
Company raise · Closed · Offering $8.8M · Sold $8.8M · PONTE VEDRA, FL · filed 2026-07-15
Placement agent engaged
45
Cadrenal Therapeutics, Inc. raises $4.4M under Reg D
Company raise · Closed · PONTE VEDRA, FL · Form D filed 2025-12-31
Placement agent engaged
Why now — by persona
Relevant to: Executive & technical recruiting, B2B software & services sales, Commercial banking / treasury, D&O and management-liability insurance, Outsourced accounting / CFO. Lead card pending.
People on the filing
| JOHN R. MURPHY | Director |
| LEE S. GOLDEN | Director |
| MATTHEW K. SZOT | Chief Financial Officer |
| JEFFREY K. COLE | Chief Operating Officer |
| QUANG X. PHAM | Chief Executive Officer |
| JAMES J. FERGUSON | Chief Medical Officer |
| GLYNN J. WILSON | Director |
| STEVEN J. ZELENKOFSKE | Director |
Signed by QUANG X. PHAM, Chief Executive Officer.
Placement agents / sales compensation: H.C. Wainwright & Co., LLC
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.
Other filings by this issuer
45
Cadrenal Therapeutics, Inc. raises $7.9M under Reg D
Company raise · Closed · Offering $7.9M · Sold $7.9M · PONTE VEDRA, FL · filed 2026-04-06
Placement agent engaged
50
Cadrenal Therapeutics, Inc. raises $9.4M under Reg D
Company raise · Closed · Offering $9.4M · Sold $9.4M · PONTE VEDRA, FL · filed 2024-11-14
Placement agent engagedNon-accredited investors